Tiling R - Search Results

1

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

Dose-Schwarz J, Tiling R, Avril-Sassen S, Mahner S, Lebeau A, Weber C, Schwaiger M, Jänicke F, Untch M, Avril N. Dose-Schwarz J, et al. Among authors: tiling r. Br J Cancer. 2010 Jan 5;102(1):35-41. doi: 10.1038/sj.bjc.6605427. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920815 Free PMC article. Clinical Trial.

2

18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.

Tiling R, Linke R, Untch M, Richter A, Fieber S, Brinkbäumer K, Tatsch K, Hahn K. Tiling R, et al. Eur J Nucl Med. 2001 Jun;28(6):711-20. doi: 10.1007/s002590100539. Eur J Nucl Med. 2001. PMID: 11440031 Clinical Trial.

3

[Breast scintigraphy using 99mTc-sestamibi--use and limitations].

Tiling R, Linke R, Kessler M, Untch M, Sommer H, Brinkbäumer K, Becker I, Hahn K. Tiling R, et al. Nuklearmedizin. 2002 Jun;41(3):148-56. Nuklearmedizin. 2002. PMID: 12109035 German.

4

Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.

Tiling R, Kessler M, Untch M, Sommer H, Linke R, Brinkbäumer K, Hahn K. Tiling R, et al. Onkologie. 2003 Feb;26(1):27-31. doi: 10.1159/000069860. Onkologie. 2003. PMID: 12624514 Free article.

5

Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.

Tiling R, Kessler M, Untch M, Sommer H, Linke R, Hahn K. Tiling R, et al. Eur J Radiol. 2005 Feb;53(2):206-12. doi: 10.1016/j.ejrad.2004.02.006. Eur J Radiol. 2005. PMID: 15664284

6

[Preoperative imaging of Charcot neuroarthropathy: Does the additional application of (18)F-FDG-PET make sense?].

Höpfner S, Krolak C, Kessler S, Tiling R. Höpfner S, et al. Among authors: tiling r. Nuklearmedizin. 2006;45(1):15-20. doi: 10.1267/nukl06010015. Nuklearmedizin. 2006. PMID: 16493510 German.

7

FDG-PET and FDG-PET/CT in breast cancer.

Haug A, Tiling R, Sommer HL. Haug A, et al. Among authors: tiling r. Recent Results Cancer Res. 2008;170:125-40. doi: 10.1007/978-3-540-31203-1_10. Recent Results Cancer Res. 2008. PMID: 18019622 Review. No abstract available.

8

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

Schwarz-Dose J, Untch M, Tiling R, Sassen S, Mahner S, Kahlert S, Harbeck N, Lebeau A, Brenner W, Schwaiger M, Jaenicke F, Avril N. Schwarz-Dose J, et al. Among authors: tiling r. J Clin Oncol. 2009 Feb 1;27(4):535-41. doi: 10.1200/JCO.2008.17.2650. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075273

9

Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.

Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, Reiser MF, Hermann KA. Schmidt GP, et al. Among authors: tiling r. Eur Radiol. 2009 Jun;19(6):1366-78. doi: 10.1007/s00330-008-1289-y. Epub 2009 Feb 4. Eur Radiol. 2009. PMID: 19190917

10

[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].

Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K. Pöpperl G, et al. Among authors: tiling r. Rofo. 2002 Jun;174(6):714-20. doi: 10.1055/s-2002-32215. Rofo. 2002. PMID: 12063600 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page